title: Neurological deterioration in patients with urea cycle disorders under valproate therapy--a cause for concern.
authors.forename: A C
authors.initials: AC
authors.lastname: Sewell
authors.forename: H J
authors.initials: HJ
authors.lastname: Böhles
authors.forename: J
authors.initials: J
authors.lastname: Herwig
authors.forename: M
authors.initials: M
authors.lastname: Demirkol
mesh_terms: D000293:Adolescent; D000592:Amino Acid Metabolism, Inborn Errors / Q000150:complications* / Q000201:enzymology; D000641:Ammonia / Q000097:blood*; D001120:Arginine / Q000097:blood*; D002648:Child; D004827:Epilepsy / Q000188:drug therapy* / Q000201:enzymology; D005260:Female; D006801:Humans; D020162:Hyperargininemia; D009460:Neurologic Examination / Q000187:drug effects*; D012307:Risk Factors; D014635:Valproic Acid / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D014635:Valproic Acid; D000641:Ammonia; D001120:Arginine